Cargando…

Human B Cell Responses to Dominant and Subdominant Antigens Induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I Trial

Neisseria meningitidis outer membrane vesicle (OMV) vaccines are safe and provide strain-specific protection against invasive meningococcal disease (IMD) primarily by inducing serum bactericidal antibodies against the outer membrane proteins (OMP). To design broader coverage vaccines, knowledge of t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rollier, Christine S., Dold, Christina, Marsay, Leanne, Linder, Aline, Green, Christopher A., Sadarangani, Manish, Norheim, Gunnstein, Derrick, Jeremy P., Feavers, Ian M., Maiden, Martin C. J., Pollard, Andrew J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791392/ https://www.ncbi.nlm.nih.gov/pubmed/35080470 http://dx.doi.org/10.1128/msphere.00674-21

Ejemplares similares

A novel meningococcal outer membrane vesicle vaccine with constitutive expression of FetA: A phase I clinical trial
por: Marsay, L., et al.
Publicado: (2015)

FetA Antibodies Induced by an Outer Membrane Vesicle Vaccine Derived from a Serogroup B Meningococcal Isolate with Constitutive FetA Expression
por: Sanders, Holly, et al.
Publicado: (2015)

Impact of Reducing Complement Inhibitor Binding on the Immunogenicity of Native Neisseria meningitidis Outer Membrane Vesicles
por: Daniels-Treffandier, Helene, et al.
Publicado: (2016)

Comparative transcriptomics between species attributes reactogenicity pathways induced by the capsular group B meningococcal vaccine, 4CMenB, to the membrane-bound endotoxin of its outer membrane vesicle component
por: Sheerin, Dylan, et al.
Publicado: (2019)

Adjuvant Effects Elicited by Novel Oligosaccharide Variants of Detoxified Meningococcal Lipopolysaccharides on Neisseria meningitidis Recombinant PorA Protein: A Comparison in Mice
por: Mehta, Ojas H., et al.
Publicado: (2014)

Recent Progress in the Prevention of Serogroup B Meningococcal Disease
por: Feavers, Ian M., et al.
Publicado: (2017)

Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine
por: Weissmueller, Nikolas T., et al.
Publicado: (2017)

Association between population prevalence of smoking and incidence of meningococcal disease in Norway, Sweden, Denmark and the Netherlands between 1975 and 2009: a population-based time series analysis
por: Norheim, Gunnstein, et al.
Publicado: (2014)

An OMV Vaccine Derived from a Capsular Group B Meningococcus with Constitutive FetA Expression: Preclinical Evaluation of Immunogenicity and Toxicity
por: Norheim, Gunnstein, et al.
Publicado: (2015)

Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity
por: Albarrak, Saleh M., et al.
Publicado: (2012)

Characterisation of the Immunomodulatory Effects of Meningococcal Opa Proteins on Human Peripheral Blood Mononuclear Cells and CD4(+) T Cells
por: Jones, Claire, et al.
Publicado: (2016)

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine
por: O’Connor, Daniel, et al.
Publicado: (2020)

Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine
por: Sadarangani, Manish, et al.
Publicado: (2012)

Inclusion of a dual signal sequence enhances the immunogenicity of a novel viral vectored vaccine against the capsular group B meningococcus
por: Sheerin, Dylan, et al.
Publicado: (2022)

Correction: Construction of Opa-Positive and Opa-Negative Strains of Neisseria meningitidis to Evaluate a Novel Meningococcal Vaccine
por: Sadarangani, Manish, et al.
Publicado: (2013)

Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein
por: Ducken, Deirdre R., et al.
Publicado: (2015)

W135 Meningococcal Disease in Africa
por: Pollard, Andrew J., et al.
Publicado: (2003)

Prevalence and decay of maternal pneumococcal and meningococcal antibodies: A meta-analysis of type-specific decay rates
por: Voysey, Merryn, et al.
Publicado: (2017)

Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis
por: Awanye, Amaka M., et al.
Publicado: (2019)

Molecular epidemiology of meningococcal disease in England and Wales 1975–1995, before the introduction of serogroup C conjugate vaccines
por: Russell, Joanne E., et al.
Publicado: (2008)

Typing complex meningococcal vaccines to understand diversity and population structure of key vaccine antigens
por: Rodrigues, Charlene M. C., et al.
Publicado: (2019)

Variation in the Neisseria lactamica porin, and its relationship to meningococcal PorB
por: Bennett, Julia S., et al.
Publicado: (2008)

Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia
por: Mihret, Wude, et al.
Publicado: (2019)

A Meningococcal Outer Membrane Vesicle Vaccine Incorporating Genetically Attenuated Endotoxin Dissociates Inflammation from Immunogenicity
por: Dowling, David J., et al.
Publicado: (2016)

Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a Rapid and Accessible Tool That Exploits Genomic Data in Public Health and Clinical Microbiology Applications
por: Rodrigues, Charlene M. C., et al.
Publicado: (2020)

Meningococcal Disease
por: Pollard, Andrew J
Publicado: (2018)

Meningococcal carriage and disease—Population biology and evolution
por: Caugant, Dominique A., et al.
Publicado: (2009)

Factor H binding protein (fHbp)-mediated differential complement resistance of a serogroup C Neisseria meningitidis isolate from cerebrospinal fluid of a patient with invasive meningococcal disease
por: Facchetti, Alessandra, et al.
Publicado: (2021)

Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa
por: Pajon, Rolando, et al.
Publicado: (2013)

A window of opportunity: Subdominant predators can use suboptimal prey
por: Jackson, Kelly A., et al.
Publicado: (2017)

Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
por: Maiden, Martin C. J.
Publicado: (2013)

The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment
por: Maiden, Martin Christopher James
Publicado: (2019)

Meningococcal Outer Membrane Protein NhhA Triggers Apoptosis in Macrophages
por: Sjölinder, Mikael, et al.
Publicado: (2012)

Metabolic shift in the emergence of hyperinvasive pandemic meningococcal lineages
por: Watkins, Eleanor R., et al.
Publicado: (2017)

The Effect of Human Factor H on Immunogenicity of Meningococcal Native Outer Membrane Vesicle Vaccines with Over-Expressed Factor H Binding Protein
por: Beernink, Peter T., et al.
Publicado: (2012)

Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): Lessons from past programs and implications for the future
por: Holst, Johan, et al.
Publicado: (2013)

Influence of the combination and phase variation status of the haemoglobin receptors HmbR and HpuAB on meningococcal virulence
por: Tauseef, Isfahan, et al.
Publicado: (2011)

Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
por: Parsons, Andrea J., et al.
Publicado: (2022)

TCR Affinity Associated with Functional Differences between Dominant and Subdominant SIV Epitope-Specific CD8(+) T Cells in Mamu-A*01 (+) Rhesus Monkeys
por: Osuna, Christa E., et al.
Publicado: (2014)

Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice
por: Mitchell, Daniel A. J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ufnuvvp0bqu9bphohnro16h77i